Skip to content

Based on Tongue Coating Endows Stomach Qi to Discuss the Formation Mechanism of Yellow Greasy Coating on Hp-Related Gastritis

Based on Tongue Coating Endows Stomach Qi to Discuss the Formation Mechanism of Yellow Greasy Coating on Hp-Related Gastritis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042524
Enrollment
Unknown
Registered
2021-01-22
Start date
2021-01-20
Completion date
Unknown
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Sponsors

Hubei University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18-65 years; 2. Meet the diagnostic criteria of chronic gastritis (chronic superficial gastritis); 3. TCM syndrome differentiation accords with spleen and stomach damp-heat syndrome or spleen and stomach weakness syndrome; 4. PPI, H2RA and antibiotic therapy should be stopped two weeks before the 13C-urea breath test or 14C-urea breath test, and those who test positive for HP.

Exclusion criteria

Exclusion criteria: 1. Organic diseases of the digestive system (such as chronic pancreatitis, liver cirrhosis, etc.), or other systemic diseases (such as hyperthyroidism, diabetes, chronic renal insufficiency, mental and neurological diseases, etc.); or other serious underlying diseases, Such as coronary heart disease, heart failure, liver and kidney failure; 2. Persons with severe allergies; 3. Women who are breastfeeding, pregnant or planning to become pregnant: 4. Persons who have serious bad habits such as smoking, alcohol or drugs; 5. Patients who need to take non-steroidal anti-inflammatory drugs for a long period of time cannot be ruled out for patients who interfere with other drugs; 6. Those who have poor compliance and difficulty in completing this experiment, which may affect the efficacy or safety judgment.

Design outcomes

Primary

MeasureTime frame
metabolite;Flora structure;

Secondary

MeasureTime frame
Organizational form;cell cycle;

Countries

China

Contacts

Public ContactQiong Yang

Hubei University of Chinese Medicine

517222878@qq.com+86 13871461460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026